A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
https://ift.tt/qm6kFH5
from WebMD Health https://ift.tt/hNJVvWF
by
Comments
Post a Comment